A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer

Background: rhTPO and rhIL-11 are both recommended for the prophylactic treatment of chemotherapy-induced thrombocytopenia (CIT). However, there has been no head to head comparative study on the prophylactic administration of rhTPO and rhIL-11 to alleviate CIT in non-small cell lung cancer (NSCLC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yunhua, Song, Xia, Du, Fangmin, Zhao, Qiong, Liu, Li, Ma, Zhiyong, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299384/
https://www.ncbi.nlm.nih.gov/pubmed/30588257
http://dx.doi.org/10.7150/jca.26690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299384/
https://www.ncbi.nlm.nih.gov/pubmed/30588257
http://dx.doi.org/10.7150/jca.26690

Ejemplares similares